These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 7001182)

  • 1. Adrenergic mechanisms of catecholamine action on glucose homeostasis in man.
    Rizza RA; Cryer PE; Haymond MW; Gerich JE
    Metabolism; 1980 Nov; 29(11 Suppl 1):1155-63. PubMed ID: 7001182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of alpha-adrenergic stimulation and its blockade on glucose turnover in man.
    Rizza RA; Haymond MW; Miles JM; Verdonk CA; Cryer PE; Gerich JE
    Am J Physiol; 1980 May; 238(5):E467-72. PubMed ID: 6990786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man.
    Rizza RA; Cryer PE; Haymond MW; Gerich JE
    J Clin Invest; 1980 Mar; 65(3):682-9. PubMed ID: 6243675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
    Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenergic modulation of glucagon and insulin secretion in obese and lean humans.
    Atkinson RL; Dahms WT; Bray GA; Sperling MA
    Horm Metab Res; 1981 May; 13(5):249-53. PubMed ID: 7021385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
    Imura H; Kato Y; Ikeda M; Morimoto M; Yawata M
    J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenergic effects on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
    Knudtzon J
    Horm Metab Res; 1984 Aug; 16(8):415-22. PubMed ID: 6381275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epinephrine and norepinephrine are cleared through beta-adrenergic, but not alpha-adrenergic, mechanisms in man.
    Cryer PE; Rizza RA; Haymond MW; Gerich JE
    Metabolism; 1980 Nov; 29(11 Suppl 1):1114-8. PubMed ID: 6107816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epinephrine supports the postabsorptive plasma glucose concentration and prevents hypoglycemia when glucagon secretion is deficient in man.
    Rosen SG; Clutter WE; Berk MA; Shah SD; Cryer PE
    J Clin Invest; 1984 Feb; 73(2):405-11. PubMed ID: 6142057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenergic modulation of pancreatic glucagon and insulin secretion in sheep.
    Oda S; Hagino A; Ohneda A; Sasaki Y; Tsuda T
    Am J Physiol; 1988 Mar; 254(3 Pt 2):R518-23. PubMed ID: 2894779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenergic modulation of pancreatic somatostatin, insulin, and glucagon secretion: evidence for differential sensitivity of islet A, B, and D cells.
    Itoh M; Gerich JE
    Metabolism; 1982 Jul; 31(7):715-20. PubMed ID: 6123933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenergic blockade alters glucose kinetics during exercise in insulin-dependent diabetics.
    Simonson DC; Koivisto V; Sherwin RS; Ferrannini E; Hendler R; Juhlin-Dannfelt A; DeFronzo RA
    J Clin Invest; 1984 Jun; 73(6):1648-58. PubMed ID: 6327767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of somatostatin and adrenergic blockade on glucagon, insulin and glucose in exercising sheep.
    Brockman RP; Halvorson R
    Aust J Biol Sci; 1981; 34(5-6):551-60. PubMed ID: 6122438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenergic receptor and epinephrine-induced hyperglycemia and glucose tolerance.
    Skikama H; Ui M
    Am J Physiol; 1975 Oct; 229(4):962-6. PubMed ID: 1190340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of hepatic alpha- and beta-adrenergic receptor stimulation on hepatic glucose production during heavy exercise.
    Coker RH; Krishna MG; Lacy DB; Bracy DP; Wasserman DH
    Am J Physiol; 1997 Nov; 273(5):E831-8. PubMed ID: 9374667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenergic modulation of pancreatic hormone secretion in utero: studies in fetal sheep.
    Sperling MA; Christensen RA; Ganguli S; Anand R
    Pediatr Res; 1980 Mar; 14(3):203-8. PubMed ID: 6992082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α- or β-Adrenergic blockade does not affect transplanted islet cell responses to hypoglycemia in type 1 diabetes.
    Rickels MR; Bellin MD; Stefanovski D; Peleckis AJ; Dalton-Bakes C; Markmann E; Nguyen HL; Townsend RR; Hering BJ; Naji A
    Am J Physiol Endocrinol Metab; 2024 Sep; 327(3):E290-E301. PubMed ID: 38984949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A receptor mechanism for the inhibition of insulin release by epinephrine in man.
    Porte D
    J Clin Invest; 1967 Jan; 46(1):86-94. PubMed ID: 6018752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catecholamines in prevention of hypoglycemia during exercise in humans.
    Marker JC; Hirsch IB; Smith LJ; Parvin CA; Holloszy JO; Cryer PE
    Am J Physiol; 1991 May; 260(5 Pt 1):E705-12. PubMed ID: 1674642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.